{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T09:37:19Z","timestamp":1775036239793,"version":"3.50.1"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s00277-024-06113-z","type":"journal-article","created":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T01:43:37Z","timestamp":1733881417000},"page":"5071-5083","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["COVID-19 outcomes among patients with sickle cell disease or sickle cell trait compared to the general population: a systematic review and meta-analyses"],"prefix":"10.1007","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7829-1827","authenticated-orcid":false,"given":"Yachar","family":"Dawudi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Loris","family":"Azoyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthieu","family":"Bonjour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Steichen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,11]]},"reference":[{"issue":"16","key":"6113_CR1","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1056\/NEJMra1510865","volume":"376","author":"FB Piel","year":"2017","unstructured":"Piel FB, Steinberg MH, Rees DC (2017) Sickle cell disease. N Engl J Med 376(16):1561\u20131573. https:\/\/doi.org\/10.1056\/NEJMra1510865","journal-title":"N Engl J Med"},{"issue":"1","key":"6113_CR2","doi-asserted-by":"publisher","first-page":"e2011028","DOI":"10.4084\/MJHID.2011.028","volume":"3","author":"SG Ahmed","year":"2011","unstructured":"Ahmed SG (2011) The role of infection in the pathogenesis of Vaso-Occlusive Crisis in patients with Sickle Cell Disease. Mediterr J Hematol Infect Dis 3(1):e2011028. https:\/\/doi.org\/10.4084\/MJHID.2011.028","journal-title":"Mediterr J Hematol Infect Dis"},{"issue":"8","key":"6113_CR3","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.3324\/haematol.2011.055202","volume":"97","author":"F Lionnet","year":"2012","unstructured":"Lionnet F, Hammoudi N, Stojanovic KS et al (2012) Hemoglobin sickle cell disease complications: a clinical study of 179 cases. Haematologica 97(8):1136\u20131141. https:\/\/doi.org\/10.3324\/haematol.2011.055202","journal-title":"Haematologica"},{"issue":"9","key":"6113_CR4","doi-asserted-by":"publisher","first-page":"619","DOI":"10.7326\/M18-1161","volume":"169","author":"RP Naik","year":"2018","unstructured":"Naik RP, Smith-Whitley K, Hassell KL et al (2018) Clinical outcomes Associated with Sickle Cell Trait: a systematic review. Ann Intern Med 169(9):619\u2013627. https:\/\/doi.org\/10.7326\/M18-1161","journal-title":"Ann Intern Med"},{"issue":"10","key":"6113_CR5","doi-asserted-by":"publisher","first-page":"e29120","DOI":"10.1002\/jmv.29120","volume":"95","author":"T Liang","year":"2023","unstructured":"Liang T, Guo K, Ni P, Duan G, Zhang R (2023) The association of sickle cell disorder with adverse outcomes in COVID-19 patients: a meta-analysis. J Med Virol 95(10):e29120. https:\/\/doi.org\/10.1002\/jmv.29120","journal-title":"J Med Virol"},{"key":"6113_CR6","doi-asserted-by":"publisher","unstructured":"Michelon I, Vilbert M, Pinheiro IS et al (2023) COVID-19 outcomes in patients with sickle cell disease and sickle cell trait compared with individuals without sickle cell disease or trait: a systematic review and meta-analysis. eClinicalMedicine 66. https:\/\/doi.org\/10.1016\/j.eclinm.2023.102330","DOI":"10.1016\/j.eclinm.2023.102330"},{"key":"6113_CR7","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71. https:\/\/doi.org\/10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"6113_CR8","unstructured":"Prospero protocol. Accessed July 1 (2023) https:\/\/www.crd.york.ac.uk\/prospero\/display_record.php?ID=CRD42022320375"},{"key":"6113_CR9","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jclinepi.2016.01.021","volume":"75","author":"J McGowan","year":"2016","unstructured":"McGowan J, Sampson M, Salzwedel DM, Cogo E, Foerster V, Lefebvre C (2016) PRESS peer review of electronic search strategies: 2015 Guideline Statement. J Clin Epidemiol 75:40\u201346. https:\/\/doi.org\/10.1016\/j.jclinepi.2016.01.021","journal-title":"J Clin Epidemiol"},{"issue":"9","key":"6113_CR10","doi-asserted-by":"publisher","first-page":"e0138237","DOI":"10.1371\/journal.pone.0138237","volume":"10","author":"NR Haddaway","year":"2015","unstructured":"Haddaway NR, Collins AM, Coughlin D, Kirk S (2015) The role of Google Scholar in evidence reviews and its applicability to Grey Literature Searching. PLoS ONE 10(9):e0138237. https:\/\/doi.org\/10.1371\/journal.pone.0138237","journal-title":"PLoS ONE"},{"issue":"1","key":"6113_CR11","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","volume":"5","author":"M Ouzzani","year":"2016","unstructured":"Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A (2016) Rayyan\u2014a web and mobile app for systematic reviews. Syst Rev 5(1):210. https:\/\/doi.org\/10.1186\/s13643-016-0384-4","journal-title":"Syst Rev"},{"key":"6113_CR12","doi-asserted-by":"publisher","first-page":"k4597","DOI":"10.1136\/bmj.k4597","volume":"364","author":"RD Riley","year":"2019","unstructured":"Riley RD, Moons KGM, Snell KIE et al (2019) A guide to systematic review and meta-analysis of prognostic factor studies. BMJ 364:k4597. https:\/\/doi.org\/10.1136\/bmj.k4597","journal-title":"BMJ"},{"issue":"4","key":"6113_CR13","doi-asserted-by":"publisher","first-page":"280","DOI":"10.7326\/0003-4819-158-4-201302190-00009","volume":"158","author":"JA Hayden","year":"2013","unstructured":"Hayden JA, van der Windt DA, Cartwright JL, C\u00f4t\u00e9 P, Bombardier C (2013) Assessing bias in studies of prognostic factors. Ann Intern Med 158(4):280\u2013286. https:\/\/doi.org\/10.7326\/0003-4819-158-4-201302190-00009","journal-title":"Ann Intern Med"},{"issue":"2","key":"6113_CR14","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/jrsm.12","volume":"1","author":"M Borenstein","year":"2010","unstructured":"Borenstein M, Hedges LV, Higgins JPT, Rothstein HR (2010) A basic introduction to fixed-effect and random-effects models for meta-analysis. Res Synth Methods 1(2):97\u2013111. https:\/\/doi.org\/10.1002\/jrsm.12","journal-title":"Res Synth Methods"},{"key":"6113_CR15","doi-asserted-by":"publisher","first-page":"f7450","DOI":"10.1136\/bmj.f7450","volume":"348","author":"RL Grant","year":"2014","unstructured":"Grant RL (2014) Converting an odds ratio to a range of plausible relative risks for better communication of research findings. BMJ 348:f7450. https:\/\/doi.org\/10.1136\/bmj.f7450","journal-title":"BMJ"},{"issue":"7","key":"6113_CR16","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1182\/bloodadvances.2020003741","volume":"5","author":"A Singh","year":"2021","unstructured":"Singh A, Brandow AM, Panepinto JA (2021) COVID-19 in individuals with sickle cell disease\/trait compared with other black individuals. Blood Adv 5(7):1915\u20131921","journal-title":"Blood Adv"},{"key":"6113_CR17","unstructured":"R: The R Project for Statistical Computing. Accessed July 2, (2023) https:\/\/www.r-project.org\/"},{"issue":"4","key":"6113_CR18","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1136\/ebmental-2019-300117","volume":"22","author":"S Balduzzi","year":"2019","unstructured":"Balduzzi S, R\u00fccker G, Schwarzer G (2019) How to perform a meta-analysis with R: a practical tutorial. Evid Based Ment Health 22(4):153\u2013160. https:\/\/doi.org\/10.1136\/ebmental-2019-300117","journal-title":"Evid Based Ment Health"},{"issue":"1","key":"6113_CR19","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s12288-021-01482-1","volume":"38","author":"R Waghmare","year":"2022","unstructured":"Waghmare R, Chaaithanya IK, Zala S et al (2022) Outcomes of COVID-19 in pregnant women with Sickle Cell Disease in India: a Case Series. Indian J Hematol Blood Transfus 38(1):191\u2013193","journal-title":"Indian J Hematol Blood Transfus"},{"issue":"2","key":"6113_CR20","doi-asserted-by":"publisher","first-page":"368","DOI":"10.4269\/ajtmh.20-1657","volume":"105","author":"WK Resurreccion","year":"2021","unstructured":"Resurreccion WK, Hulsizer J, Shi Z et al (2021) Association of Sickle Cell Trait with Risk and Mortality of COVID-19: results from the United Kingdom Biobank. Am J Trop Med Hyg 105(2):368\u2013371. https:\/\/doi.org\/10.4269\/ajtmh.20-1657","journal-title":"Am J Trop Med Hyg"},{"key":"6113_CR21","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1182\/blood-2020-142835","volume":"136","author":"LE Merz","year":"2020","unstructured":"Merz LE, Mistry K, Freedman R et al (2020) Impact of sickle cell trait on morbidity and mortality from SARS-COV-2 infection. Blood 136:31\u201332","journal-title":"Blood"},{"issue":"8","key":"6113_CR22","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1001\/jamainternmed.2022.2141","volume":"182","author":"A Verma","year":"2022","unstructured":"Verma A, Huffman JE, Gao L et al (2022) Association of Kidney Comorbidities and acute kidney failure with unfavorable outcomes after COVID-19 in individuals with the Sickle Cell Trait. JAMA Intern Med 182(8):796\u2013804. https:\/\/doi.org\/10.1001\/jamainternmed.2022.2141","journal-title":"JAMA Intern Med"},{"issue":"9","key":"6113_CR23","doi-asserted-by":"publisher","first-page":"e632","DOI":"10.1016\/S2352-3026(20)30204-0","volume":"7","author":"JB Arlet","year":"2020","unstructured":"Arlet JB, de Luna G, Khimoud D et al (2020) Prognosis of patients with sickle cell disease and COVID-19: a French experience. Lancet Haematol 7(9):e632\u2013e634. https:\/\/doi.org\/10.1016\/S2352-3026(20)30204-0","journal-title":"Lancet Haematol"},{"issue":"7","key":"6113_CR24","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.3390\/jcm9072227","volume":"9","author":"L Gaborieau","year":"2020","unstructured":"Gaborieau L, Delestrain C, Bensaid P et al (2020) Epidemiology and clinical presentation of children hospitalized with SARS-CoV-2 infection in suburbs of Paris. J Clin Med 9(7):2227","journal-title":"J Clin Med"},{"key":"6113_CR25","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1182\/blood-2020-137676","volume":"136","author":"L Mucalo","year":"2020","unstructured":"Mucalo L, Brandow AM, Mason SF et al (2020) Hospitalization and case fatality in individuals with Sickle Cell Disease and COVID-19 infection. Blood 136:7\u20138","journal-title":"Blood"},{"issue":"9","key":"6113_CR26","doi-asserted-by":"publisher","first-page":"2950","DOI":"10.3390\/jcm9092950","volume":"9","author":"N Nathan","year":"2020","unstructured":"Nathan N, Prevost B, Sileo C et al (2020) The wide spectrum of COVID-19 clinical presentation in children. J Clin Med 9(9):2950. https:\/\/doi.org\/10.3390\/jcm9092950","journal-title":"J Clin Med"},{"issue":"5","key":"6113_CR27","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.arcped.2020.05.010","volume":"27","author":"M Oualha","year":"2020","unstructured":"Oualha M, Bendavid M, Berteloot L et al (2020) Severe and fatal forms of COVID-19 in children. Arch Pediatr 27(5):235\u2013238","journal-title":"Arch Pediatr"},{"issue":"2","key":"6113_CR28","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1002\/jha2.87","volume":"1","author":"P Ramachandran","year":"2020","unstructured":"Ramachandran P, Perisetti A, Kathirvelu B et al (2020) Low morbidity and mortality with COVID-19 in sickle cell disease: a single center experience. eJHaem 1(2):608\u2013614. https:\/\/doi.org\/10.1002\/jha2.87","journal-title":"eJHaem"},{"issue":"2","key":"6113_CR29","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1002\/jha2.170","volume":"2","author":"A Abdulrahman","year":"2021","unstructured":"Abdulrahman A, Wael M, AlAmmadi F et al (2021) Is sickle cell disease a risk factor for severe COVID-19 outcomes in hospitalized patients? A multicenter national retrospective cohort study. EJHaem 2(2):167\u2013174. https:\/\/doi.org\/10.1002\/jha2.170","journal-title":"EJHaem"},{"issue":"Supplement 1","key":"6113_CR30","doi-asserted-by":"publisher","first-page":"4170","DOI":"10.1182\/blood-2021-148846","volume":"138","author":"T Adamkiewicz","year":"2021","unstructured":"Adamkiewicz T, Mubasher M, Omole F et al (2021) Sickle cell disease (SCD) as a risk for COVI19 compared to those without SCD among patients admitted in a Large Urban Center, as estimated by PCR Sars-v-2 positive vs negative testing. Blood 138(Supplement 1):4170. https:\/\/doi.org\/10.1182\/blood-2021-148846","journal-title":"Blood"},{"issue":"1","key":"6113_CR31","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s40001-021-00517-7","volume":"26","author":"S Alhumaid","year":"2021","unstructured":"Alhumaid S, Al Mutair A, Al Alawi Z et al (2021) Clinical features and prognostic factors of intensive and non-intensive 1014 COVID-19 patients: an experience cohort from Alahsa, Saudi Arabia. Eur J Med Res 26(1):47. https:\/\/doi.org\/10.1186\/s40001-021-00517-7","journal-title":"Eur J Med Res"},{"issue":"9","key":"6113_CR32","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1007\/s00277-021-04549-1","volume":"100","author":"C Bo\u011fa","year":"2021","unstructured":"Bo\u011fa C, Asma S, Leblebisatan G et al (2021) Comparison of the clinical course of COVID-19 infection in sickle cell disease patients with healthcare professionals. Ann Hematol 100(9):2195\u20132202. https:\/\/doi.org\/10.1007\/s00277-021-04549-1","journal-title":"Ann Hematol"},{"issue":"3","key":"6113_CR33","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/jpids\/piaa072","volume":"9","author":"CE Foster","year":"2021","unstructured":"Foster CE, Moulton EA, Munoz FM et al (2021) Coronavirus Disease 2019 in children cared for at texas children\u2019s hospital: initial clinical characteristics and outcomes. J Pediatr Infect Soc 9(3):373\u2013377","journal-title":"J Pediatr Infect Soc"},{"key":"6113_CR34","unstructured":"Levine-Ritterman M Severe complications from COVID-19 in US children and adolescents with sickle cell disease. Published online 2021."},{"key":"6113_CR35","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jpeds.2022.02.048","volume":"245","author":"JI Campbell","year":"2022","unstructured":"Campbell JI, Dubois MM, Savage TJ et al (2022) Comorbidities Associated with hospitalization and progression among adolescents with symptomatic coronavirus Disease 2019. J Pediatr 245:102\u2013110e2. https:\/\/doi.org\/10.1016\/j.jpeds.2022.02.048","journal-title":"J Pediatr"},{"issue":"24","key":"6113_CR36","doi-asserted-by":"publisher","first-page":"7361","DOI":"10.3390\/jcm11247361","volume":"11","author":"M Castonguay","year":"2022","unstructured":"Castonguay M, Dakhallah N, Desroches J et al (2022) COVID-19 and Sickle Cell Disease in the Province of Quebec, Canada: outcomes after two years of the pandemic. J Clin Med 11(24):7361. https:\/\/doi.org\/10.3390\/jcm11247361","journal-title":"J Clin Med"},{"issue":"Issue 1","key":"6113_CR37","doi-asserted-by":"publisher","first-page":"10","DOI":"10.33696\/diabetes.4.050","volume":"4","author":"C Dun","year":"2022","unstructured":"Dun C, Walsh CM, Bae S et al (2022) A machine learning study of 534,023 Medicare Beneficiaries with COVID-19: implications for personalized risk prediction for people over 65. J Diabetes Clin Res 4(Issue 1):10\u201316. https:\/\/doi.org\/10.33696\/diabetes.4.050","journal-title":"J Diabetes Clin Res"},{"issue":"Suppl","key":"6113_CR38","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1097\/01.HS9.0000851696.75163.ac","volume":"6","author":"V Goyal","year":"2022","unstructured":"Goyal V, Singh A, Memon Y, Thakre N, Sahu P, Goyal R, PB2217: SICKLE CELL DISEASE IS A RISK FACTOR FOR THE PROGRESSION AND PROGNOSIS OF COVID-19 (2022) HemaSphere 6(Suppl):2087\u20132088. https:\/\/doi.org\/10.1097\/01.HS9.0000851696.75163.ac","journal-title":"HemaSphere"},{"key":"6113_CR39","doi-asserted-by":"publisher","first-page":"05044","DOI":"10.7189\/jogh.12.05044","volume":"12","author":"T Shi","year":"2022","unstructured":"Shi T, Pan J, Moore E et al (2022) Risk of COVID-19 hospitalizations among school-aged children in Scotland: a national incident cohort study. J Glob Health 12:05044. https:\/\/doi.org\/10.7189\/jogh.12.05044","journal-title":"J Glob Health"},{"issue":"1","key":"6113_CR40","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/s41591-021-01627-9","volume":"28","author":"JL Ward","year":"2022","unstructured":"Ward JL, Harwood R, Smith C et al (2022) Risk factors for PICU admission and death among children and young people hospitalized with COVID-19 and PIMS-TS in England during the first pandemic year. Nat Med 28(1):193\u2013200. https:\/\/doi.org\/10.1038\/s41591-021-01627-9","journal-title":"Nat Med"},{"issue":"10","key":"6113_CR41","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.7326\/M21-1375","volume":"174","author":"AK Clift","year":"2021","unstructured":"Clift AK, Saatci D, Coupland CAC, Dambha-Miller H, Hippisley-Cox J (2021) Sickle Cell disorders and severe COVID-19 outcomes: a Cohort Study. Ann Intern Med 174(10):1483\u20131487","journal-title":"Ann Intern Med"},{"issue":"11","key":"6113_CR42","doi-asserted-by":"publisher","first-page":"3014","DOI":"10.3324\/haematol.2021.279222","volume":"106","author":"WS Hoogenboom","year":"2021","unstructured":"Hoogenboom WS, Fleysher R, Soby S et al (2021) Individuals with sickle cell disease and sickle cell trait demonstrate no increase in mortality or critical illness from COVID-19 - a fifteen hospital observational study in the Bronx, New York. Haematologica 106(11):3014\u20133016. https:\/\/doi.org\/10.3324\/haematol.2021.279222","journal-title":"Haematologica"},{"issue":"4","key":"6113_CR43","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1097\/MPH.0000000000002671","volume":"45","author":"ST Paulukonis","year":"2023","unstructured":"Paulukonis ST, Snyder A, Smeltzer MP et al (2023) COVID-19 infection and outcomes in newborn screening cohorts of Sickle Cell Trait and Sickle Cell Disease in Michigan and Georgia. J Pediatr Hematol Oncol 45(4):174\u2013180. https:\/\/doi.org\/10.1097\/MPH.0000000000002671","journal-title":"J Pediatr Hematol Oncol"},{"key":"6113_CR44","doi-asserted-by":"publisher","first-page":"99228221150605","DOI":"10.1177\/00099228221150605","volume":"20","author":"SP Ungar","year":"2023","unstructured":"Ungar SP, Solomon S, Stachel A et al (2023) Hospital and ICU admission risk Associated with comorbidities among Children with COVID-19 ancestral strains. Clin Pediatr (Phila). Published Online January 20:99228221150605. https:\/\/doi.org\/10.1177\/00099228221150605","journal-title":"Published Online January"},{"key":"6113_CR45","doi-asserted-by":"publisher","first-page":"975826","DOI":"10.3389\/fped.2022.975826","volume":"10","author":"B Pr\u00e9vost","year":"2022","unstructured":"Pr\u00e9vost B, Retbi A, Binder-Foucard F et al (2022) Risk factors for admission to the pediatric critical care unit among children hospitalized with COVID-19 in France. Front Pediatr 10:975826. https:\/\/doi.org\/10.3389\/fped.2022.975826","journal-title":"Front Pediatr"},{"key":"6113_CR46","doi-asserted-by":"publisher","first-page":"757510","DOI":"10.3389\/fmed.2021.757510","volume":"8","author":"JX Lee","year":"2021","unstructured":"Lee JX, Chieng WK, Lau SCD, Tan CE (2021) COVID-19 and hemoglobinopathies: a systematic review of clinical presentations, investigations, and outcomes. Front Med 8:757510. https:\/\/doi.org\/10.3389\/fmed.2021.757510","journal-title":"Front Med"},{"issue":"3","key":"6113_CR47","doi-asserted-by":"publisher","first-page":"362","DOI":"10.7326\/M20-6306","volume":"174","author":"K Mackey","year":"2021","unstructured":"Mackey K, Ayers CK, Kondo KK et al (2021) Racial and ethnic disparities in COVID-19-Related infections, hospitalizations, and deaths: a systematic review. Ann Intern Med 174(3):362\u2013373. https:\/\/doi.org\/10.7326\/M20-6306","journal-title":"Ann Intern Med"},{"issue":"11","key":"6113_CR48","doi-asserted-by":"publisher","first-page":"e2134147","DOI":"10.1001\/jamanetworkopen.2021.34147","volume":"4","author":"S Magesh","year":"2021","unstructured":"Magesh S, John D, Li WT et al (2021) Disparities in COVID-19 outcomes by race, ethnicity, and Socioeconomic Status. JAMA Netw Open 4(11):e2134147. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.34147","journal-title":"JAMA Netw Open"},{"issue":"1","key":"6113_CR49","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1182\/bloodadvances.2020003456","volume":"5","author":"CP Minniti","year":"2021","unstructured":"Minniti CP, Zaidi AU, Nouraie M et al (2021) Clinical predictors of poor outcomes in patients with sickle cell disease and COVID-19 infection. Blood Adv 5(1):207\u2013215. https:\/\/doi.org\/10.1182\/bloodadvances.2020003456","journal-title":"Blood Adv"},{"issue":"2","key":"6113_CR50","doi-asserted-by":"publisher","first-page":"e8","DOI":"10.1111\/bjh.18409","volume":"199","author":"S Eyssette-Guerreau","year":"2022","unstructured":"Eyssette-Guerreau S, Khimoud D, Michaux K et al (2022) Severe cases of COVID-19 in children with sickle cell disease during the Omicron wave in France: a plea for vaccination. Br J Haematol 199(2):e8\u2013e11. https:\/\/doi.org\/10.1111\/bjh.18409","journal-title":"Br J Haematol"},{"key":"6113_CR51","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.ijid.2021.03.044","volume":"106","author":"S Alkindi","year":"2021","unstructured":"Alkindi S, Elsadek RA, Al-Madhani A et al (2021) Impact of COVID-19 on vasooclusive crisis in patients with sickle cell anaemia. Int J Infect Dis 106:128\u2013133. https:\/\/doi.org\/10.1016\/j.ijid.2021.03.044","journal-title":"Int J Infect Dis"},{"issue":"12","key":"6113_CR52","doi-asserted-by":"publisher","first-page":"e29351","DOI":"10.1002\/pbc.29351","volume":"68","author":"AB Payne","year":"2021","unstructured":"Payne AB, Adamkiewicz TV, Grosse SD et al (2021) Influenza vaccination rates and hospitalizations among Medicaid enrollees with and without sickle cell disease, 2009\u20132015. Pediatr Blood Cancer 68(12):e29351. https:\/\/doi.org\/10.1002\/pbc.29351","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"6113_CR53","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1080\/03630269.2023.2219847","volume":"47","author":"T Silva Borborema","year":"2023","unstructured":"Silva Borborema T, Moreira Brito JC, Lima Batista EM, Siqueira Batista R (2023) Case Fatality Rate and Severity of COVID-19 among patients with Sickle Cell Disease: a systematic review and Meta-analysis. Hemoglobin 47(2):85\u201396. https:\/\/doi.org\/10.1080\/03630269.2023.2219847","journal-title":"Hemoglobin"},{"issue":"7","key":"6113_CR54","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/j.jamda.2020.05.045","volume":"21","author":"C Bonanad","year":"2020","unstructured":"Bonanad C, Garc\u00eda-Blas S, Tarazona-Santabalbina F et al (2020) The Effect of Age on Mortality in patients with COVID-19: a Meta-analysis with 611,583 subjects. J Am Med Dir Assoc 21(7):915\u2013918. https:\/\/doi.org\/10.1016\/j.jamda.2020.05.045","journal-title":"J Am Med Dir Assoc"},{"key":"6113_CR55","doi-asserted-by":"crossref","unstructured":"Hoogenboom WS, Alamuri TT, McMahon DM et al (2022) Clinical outcomes of COVID-19 in patients with sickle cell disease and sickle cell trait: a critical appraisal of the literature. Blood Rev.;53. https:\/\/www.embase.com\/search\/results?subaction=viewrecord&id=L2015744015&from=export U2 - L2015744015","DOI":"10.1016\/j.blre.2021.100911"},{"key":"6113_CR56","doi-asserted-by":"crossref","unstructured":"Hippisley-Cox J, Coupland CAC, Mehta N et al (2021) Risk prediction of covid-19 related death and hospital admission in adults after covid-19 vaccination: National prospective cohort study. BMJ.;374. https:\/\/www.embase.com\/search\/results?subaction=viewrecord&id=L636014133&from=export U2 - L636014133","DOI":"10.1136\/bmj.n2244"},{"issue":"10","key":"6113_CR57","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.3201\/eid2610.202792","volume":"26","author":"JA Panepinto","year":"2020","unstructured":"Panepinto JA, Brandow A, Mucalo L et al (2020) Coronavirus disease among persons with Sickle Cell Disease, United States, March 20-May 21, 2020. Emerg Infect Dis 26(10):2473\u20132476","journal-title":"Emerg Infect Dis"},{"key":"6113_CR58","doi-asserted-by":"publisher","unstructured":"Arlet J, Lionnet F, Khimoud D et al (2022) Risk factors for severe COVID -19 in hospitalized sickle cell disease patients: a study of 319 patients in France. Am J Hematol 97(3). https:\/\/doi.org\/10.1002\/ajh.26432","DOI":"10.1002\/ajh.26432"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-024-06113-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-024-06113-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-024-06113-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T01:16:12Z","timestamp":1735866972000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-024-06113-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":58,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["6113"],"URL":"https:\/\/doi.org\/10.1007\/s00277-024-06113-z","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"3 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}